Stay updated with breaking news from Global Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
For Trade and Medical Media Only Rezafungin is a next-generation once-weekly echinocandin being developed for both the treatment and prevention of serious fungal infections, such as invasive candidiasis
Investegate announcements from Centessa Pharmaceuticals plc, Centessa Pharmaceuticals Doses First Subject in Global Phase 3 ACTION Study of Lixivaptan in Autosomal Dominant Polycystic Kidney Disease
Investegate announcements from Hutchmed China Ltd, HUTCHMED Completes Planned Enrollment of FRESCO-2
A JAK1 selective inhibitor could soon become a standard treatment option for people with atopic dermatitis, according to a new Irish study. The findings
E-Mail Newly published papers further elucidate the mechanisms underlying pridopidine's neuroprotective properties through activation of the Sigma-1 Receptor (S1R). Pridopidine enhances mitochondrial function and reduces mHTT-induced ER stress, which are impaired in HD, mediated by the S1R. Three new peer-reviewed publications highlight pridopidine's therapeutic potential and provide data supporting the role of the S1R in neurodegenerative diseases Prilenia Therapeutics B.V., a clinical stage biotech company focused on developing novel treatments for neurodegenerative...